IGC
Igc Pharma, Inc.
$0.32+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
IGC Pharma, Inc. (IGC) is a publicly traded company with 12 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 4 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 22 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | 2026-04-01 | Prins Richard K | Director | Exercise Conversion | 70,000 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Prins Richard K | Director | Exercise Conversion | 100,000 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Mukunda Ram | CEO | Exercise Conversion | 323,077 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Mukunda Ram | CEO | Exercise Conversion | 16,667 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Mukunda Ram | CEO | Exercise Conversion | 33,332 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Mukunda Ram | CEO | Exercise Conversion | 323,077 | $0.26 | $84,000 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Mukunda Ram | CEO | Exercise Conversion | 333,333 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Moran James P | Director | Exercise Conversion | 50,000 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Moran James P | Director | Exercise Conversion | 80,000 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-01 | Grimaldi Claudia | PFO | Exercise Conversion | 138,462 | $0.00 | $0 | N/A | N/A |
IGC
Director
Exercise Conversion
$0
Prins Richard K70,000 shares @ $0.00
Filed 2026-04-06Trade 2026-04-01
IGC
Director
Exercise Conversion
$0
Prins Richard K100,000 shares @ $0.00
Filed 2026-04-06Trade 2026-04-01
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.